Effect of Dexmedetomidine on serum inflammatory factors and neurocytokines levels and prognosis in patients with severe craniocerebral injury after surgery
GAO Jian1 ZHANG Hua1 LIU Guocheng1 WANG Decong1 ZHAO Zeyu2▲
1.Department of Critical Care Medicine, People’s Hospital of Pidu District in Chengdu City, Sichuan Province, Chengdu 611730, China;
2.Department of Anesthesiology, Sichuan China 81 Rehabilitation Center Affiliated to Chengdu University of Traditional Chinese Medicine, Sichuan Province, Chengdu 611135, China
Abstract：Objective To investigate the effect of Dexmedetomidine (DEX) on serum inflammatory factors and neurocytokines levels and prognosis in patients with severe craniocerebral injury after surgery. Methods From January 2017 to December 2019, 50 patients with severe craniocerebral injury admitted to intensive care unit (ICU) of Pidu District People’s Hospital of Chengdu City were selected and divided into group D and group C according to random number table method, 25 cases in each group. Group D received DEX 0.5-0.8 μg/(kg·h), group C received Midazolam 0.05-0.1 mg/(kg·h) for seven days. NIHSS scores were used to evaluate the degree of neurological deficit and intracranial pressure (ICP) at the time of admission to ICU (T0) and seven days after treatment (T1) in two groups. The incidence of complications of two groups was recorded at T1. Peripheral venous blood samples were collected at T0 and T1 to determine the levels of interleukin-6 (IL-6), tumor necrosis factor-α (TNF-α), central nerve specific protein (S100β), neuron specific enolase (NSE). The length of ICU stay and the total length of stay of two groups were recorded, and the prognosis was evaluated of two groups after three months. Results NIHSS score and ICP at T1 were lower than those at T0 in two groups (P < 0.01). NIHSS score and ICP at T1 in group D were lower than those in group C (P < 0.05 or P < 0.01). Total complication rate at T1 in group D was lower than that in group C (P < 0.01). The levels of IL-6 and TNF-α at T1 were significantly lower than those at T0 in two groups (P < 0.01). The levels of IL-6 and TNF-α at T1 in group D were lower than those in group C (P < 0.05 or P < 0.01). The levels of S100β and NSE at T1 were higher than those at T0 in two groups (P < 0.01). At T1, S100β and NSE levels in group D were lower than those in group C (P < 0.01). The length of ICU stay and total length of stay in group D were shorter than those in group C (P < 0.05 or P < 0.01). The prognosis of group D was better than that of group C after three months (P < 0.05). Conclusion DEX can reduce the degree of neurological deficit, reduce the incidence of ICP and complications, shorten the length of ICU stay and total hospital stay and improve the prognosis of patients.
高见1 张华1 刘国成1 汪德聪1 赵泽宇2▲. 右美托咪定对重型颅脑损伤患者术后血清炎症因子和神经细胞因子水平及预后的影响[J]. 中国医药导报, 2021, 18(1): 111-114,139.
GAO Jian1 ZHANG Hua1 LIU Guocheng1 WANG Decong1 ZHAO Zeyu2▲. Effect of Dexmedetomidine on serum inflammatory factors and neurocytokines levels and prognosis in patients with severe craniocerebral injury after surgery. 中国医药导报, 2021, 18(1): 111-114,139.
[1] 水庆学，孙洪娣，田落意.重型颅脑损伤开颅术后继发急性脑梗死的危险因素[J].中国临床神经外科杂志，2019， 24（10）：624-626.
[2] 史立信，马志军，王清涛，等.血必净注射液对急性重型颅脑损伤患者多器官功能的影响[J].中国实用神经疾病杂志，2017，20（4）：11-14.
[3] Xu J，Lei S，Ye G. Dexmedetomidine attenuates oxidative/nitrative stress in lung tissues of septicmice partly via activating heme oxygenase [J]. Exp Ther Med，2019，18（4）：3071-3077.
[4] 李晶，李铁成，陈晓宇.羟考酮注射液复合右美托咪定用于剖宫产术后镇痛的可行性及效果观察[J].中国医科大学学报，2020，49（6）：551-555.
[5] 马海波，杨迎春，刘晶晶，等.右美托咪定对脑缺血再灌注损伤小鼠糖萼的影响[J].中国医药导报，2020，17（13）：8-12，26.
[6] Liao XZ，Liu YF，Yang LK，et al. Protective effect and mechanism of hydrochloride dexmedetomidine on the severe craniocerebral trauma in rats [J]. Int J Clin Exp Med，2017，10（5）：8522-8528.
[7] 加重继发性脑损伤危险因素防治专家共识专家组.颅脑创伤后加重继发性脑损伤的危险因素防治专家共识[J].临床神经外科杂志，2020，17（3）：241-249，253.
[8] 汤锦丽，顾艳，费雅雅，等.基于NIHSS评分的干预模式对重型颅脑损伤术后患者的影响[J].中国医药导报，2020， 17（14）：69-72，77.
[9] 李彦君，杨晓涛.标准大骨瓣开颅减压手术对重型颅脑损伤患者NIHSS评分的影响[J].中国药物与临床，2020， 20（10）：1640-1641.
[10] 王威，方向明，张占琴.右旋美托咪啶用于脓毒症患者镇静的剂量-效应关系研究[J].中华急诊医学杂志，2015， 24（8）：911-912.
[11] 赵泽宇，程庆，张蓉，等.不同剂量右美托咪定用于帕金森病患者脑深部电刺激术镇静效果的比较[J].中华麻醉学杂志，2018，38（11）：1285-1287.
[12] Kim E，Kim MS，Kim Y. Vessel wall magnetic resonance imaging in a case of post-traumatic multifocal striatocapsular hemorrhagic infarction [J]. Neurol Med Chir（Tokyo），2019，59（5）：191-195.
[13] 汪慧娟，郑红云，袁强，等.体位对颅脑损伤患者颅内压、脑灌注压的影响[J].中华急诊医学杂志，2016，25（9）：1197-1199.
[14] Chen ZF. Clinical study on the relationship of the short duration of use midazolam with the occurrence of delirium in ICU patients with mechanical ventilation [J]. Farmacia，2020，68（1）：164-169.
[15] 杜秀玉，翟晓东，刘志，等.芬太尼联合咪达唑仑镇痛镇静在神经外科重症患者改良经皮气管切开中的应用效果[J].中国医药导报，2020，17（16）：109-111，138.
[16] Guedes A，Knych H，Tucker L，et al. Pharmacokinetics and clinical effects of xylazine and dexmedetomidine in horses recovering from isoflurane anesthesia [J]. J Vet Pharmacol Ther，2020，43（4）：369-376.
[17] 史记，张娜娜，赵帅，等.盐酸右美托咪定对颅内动脉瘤介入手术患者血流动力学及术后并发症的影响[J].中国医药导报，2020，17（7）：115-119.
[18] Fu C，Dai X，Yang Y，et al. Dexmedetomidine attenuates lipopolysaccharide-induced acute lung injury by inhibiting oxidative stress，mitochondrial dysfunction and apoptosis in rats [J]. Mol Med Rep，2016，15（1）：131-138.
[19] 史锐，朱振军，杨永波.牛磺酸调节白介素水平对椎间盘退变大鼠模型髓核细胞凋亡、炎症和氧化应激的保护作用[J].中国免疫学杂志，2020，36（9）：1097-1102.
[20] 吴夏楠，罗艳，邹鳞，等.IL-34诱导肺成纤维细胞IL-6、IL-8表达机制研究[J].中国免疫学杂志，2020，36（4）：405-410.
[21] 夏黎，林欣，孙岩，等.右美托咪定对甲醛致疼痛小鼠炎症介质释放的干预研究[J].中华危重症医学杂志：电子版，2020，13（2）：118-123.
[22] Yang Y，Qin X，Han CG，et al. Effect of different doses of dexmedetomidine on lung function and tissue cell apoptosis in a rat model of hyperoxic acute lung injury [J]. Rop J Pharm Res，2020，19（5）：1093-1098.
[23] 张丽梅，贾莉莉，喻文立.细胞焦亡在肝缺血再灌注大鼠脑损伤中的作用[J].中华麻醉学杂志，2019，39（9）：1058-1061.
[24] 牛莉莉，闫文萍，马红萍，等.血清、脑脊液中S-100B、NSE水平与缺血性脑卒中的研究[J].国际检验医学杂志，2020，41（3）：285-289.
2021, Vol. 18 
京公网安备 11010502046598号